Takei Hisato, Yamamoto Masahiro, Kase Yoshio, Takeda Shuichi
Tsumura Research Institute, Tsumura and Co., Ibaraki, Japan.
J Pharmacol Sci. 2005 Jul;98(3):255-62. doi: 10.1254/jphs.fpj04043x. Epub 2005 Jul 2.
The chronic inhibition of nitric oxide (NO) synthesis with N(omega)-nitro-L-arginine methyl ester (L-NAME) in pregnant rats induces a pre-eclampsia-like syndrome, including hypertension. We have previously reported the beneficial effects of Toki-shakuyaku-san (TS) in this model. In the present study we demonstrated the anti-hypertensive effect of TS in pre-eclampsia produced by prolonged L-NAME-infusion during the postpartum period. Analysis of blood sex steroids suggested that the level of progesterone differs between the TS-effective (gestational day 19 and postpartum day 7) and TS-ineffective (postpartum day 1) periods. Co-administration of TS and progesterone inhibited L-NAME-induced hypertension on postpartum day 1. Furthermore, the anti-hypertensive effect of TS on postpartum day 6 disappeared in the presence of a co-administered progesterone antagonist mifepristone. These data suggest that a certain level of progesterone may be an indispensable prerequisite for an anti-hypertensive effect of TS. Finally, the effects of TS are apparently unrelated to blood levels of NO, calcitonin gene-related peptide, and endothelin-1, which have been reported to modulate systolic blood pressure in the L-NAME-induced pre-eclampsia model. Thus, the use of TS may provide a new therapeutic strategy for pre-eclampsia, although elucidation of the mechanism of action of TS would be necessary to optimize treatment protocols.
用N(ω)-硝基-L-精氨酸甲酯(L-NAME)慢性抑制妊娠大鼠体内一氧化氮(NO)的合成会诱发先兆子痫样综合征,包括高血压。我们之前已报道了桂枝茯苓丸(TS)在此模型中的有益作用。在本研究中,我们证明了TS对产后长期输注L-NAME所致先兆子痫的降压作用。血液中性类固醇分析表明,TS有效(妊娠第19天和产后第7天)和TS无效(产后第1天)时期的孕酮水平有所不同。TS与孕酮联合给药可抑制产后第1天L-NAME诱导的高血压。此外,在联合使用孕酮拮抗剂米非司酮的情况下,TS在产后第6天的降压作用消失。这些数据表明,一定水平的孕酮可能是TS产生降压作用必不可少的前提条件。最后,TS的作用显然与NO、降钙素基因相关肽和内皮素-1的血药浓度无关,而据报道这些物质可调节L-NAME诱导的先兆子痫模型中的收缩压。因此,使用TS可能为先兆子痫提供一种新的治疗策略,不过要优化治疗方案,还需要阐明TS的作用机制。